Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sofosbuvir Plus Daclatasvir With or Without Ribavirin: Large Real-life Results of Patients With Chronic Hepatitis C Genotype 4

NCT04387526 is registered in ClinicalTrials.gov with Beni-Suef University as lead sponsor.

NCT NCT04387526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04387526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sofosbuvir Plus Daclatasvir With or Without Ribavirin: Large Real-life Results of Patients With Chronic Hepatitis C Genotype 4
Lead sponsor
Beni-Suef University
Phase
Phase 2/3
Overall status
Completed
Start date
April 1, 2016
Completion date
May 31, 2017
Enrollment
946 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c virus infection